Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Decrease in oxidized high-density lipoprotein is associated with slowed progression of coronary artery calcification: Subanalysis of a prospective multicenter study.

Miki T, Miyoshi T, Kotani K, Kohno K, Asonuma H, Sakuragi S, Koyama Y, Nakamura K, Ito H.

Atherosclerosis. 2019 Apr;283:1-6. doi: 10.1016/j.atherosclerosis.2019.01.032. Epub 2019 Feb 1.

PMID:
30769272
2.

Tobacco smoking protective effect via remote ischemic preconditioning on myocardial damage after elective percutaneous coronary intervention: Subanalysis of a randomized controlled trial.

Ejiri K, Miyoshi T, Kohno K, Nakahama M, Doi M, Munemasa M, Murakami M, Takaishi A, Nakamura K, Ito H.

Int J Cardiol Heart Vasc. 2018 Dec 26;22:55-60. doi: 10.1016/j.ijcha.2018.12.005. eCollection 2019 Mar.

3.

High Baseline Lipoprotein(a) Level as a Risk Factor for Coronary Artery Calcification Progression: Sub-analysis of a Prospective Multicenter Trial.

Ida J, Kotani K, Miyoshi T, Nakamura K, Kohno K, Asonuma H, Sakuragi S, Doi M, Miki T, Koyama Y, Ito H.

Acta Med Okayama. 2018 Jun;72(3):223-230. doi: 10.18926/AMO/56067.

4.

Protective Effect of Remote Ischemic Preconditioning on Myocardial Damage After Percutaneous Coronary Intervention in Stable Angina Patients With Complex Coronary Lesions - Subanalysis of a Randomized Controlled Trial.

Ejiri K, Miyoshi T, Kohno K, Nakahama M, Doi M, Munemasa M, Murakami M, Takaishi A, Nakamura K, Ito H; RINC Study Collaborators.

Circ J. 2018 Jun 25;82(7):1788-1796. doi: 10.1253/circj.CJ-17-1000. Epub 2018 Apr 18.

5.

Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC).

Kawakita N, Ejiri K, Miyoshi T, Kohno K, Nakahama M, Doi M, Munemasa M, Murakami M, Nakamura K, Ito H; RINC investigators.

PLoS One. 2018 Apr 16;13(4):e0194623. doi: 10.1371/journal.pone.0194623. eCollection 2018.

6.

Effect of Intensive and Standard Pitavastatin Treatment With or Without Eicosapentaenoic Acid on Progression of Coronary Artery Calcification Over 12 Months - Prospective Multicenter Study.

Miyoshi T, Kohno K, Asonuma H, Sakuragi S, Nakahama M, Kawai Y, Uesugi T, Oka T, Munemasa M, Takahashi N, Mukohara N, Habara S, Koyama Y, Nakamura K, Ito H; PEACH Investigators.

Circ J. 2018 Jan 25;82(2):532-540. doi: 10.1253/circj.CJ-17-0419. Epub 2017 Sep 1.

7.

Effect of Azilsartan on Day-to-Day Variability in Home Blood Pressure: A Prospective Multicenter Clinical Trial.

Miyoshi T, Suetsuna R, Tokunaga N, Kusaka M, Tsuzaki R, Koten K, Kunihisa K, Ito H.

J Clin Med Res. 2017 Jul;9(7):618-623. doi: 10.14740/jocmr3050w. Epub 2017 May 22.

8.

Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.

Miyoshi T, Ejiri K, Kohno K, Nakahama M, Doi M, Munemasa M, Murakami M, Takaishi A, Kawai Y, Sato T, Sato K, Oka T, Takahashi N, Sakuragi S, Mima A, Enko K, Hosogi S, Nanba S, Hirami R, Nakamura K, Ito H; RINC Study Collaborators.

Int J Cardiol. 2017 Jun 1;236:36-42. doi: 10.1016/j.ijcard.2017.02.028. Epub 2017 Feb 10.

PMID:
28214082
9.

Incidence and Clinical Significance of Brugada Syndrome Masked by Complete Right Bundle-Branch Block.

Wada T, Nagase S, Morita H, Nakagawa K, Nishii N, Nakamura K, Kohno K, Ito H, Kusano KF, Ohe T.

Circ J. 2015;79(12):2568-75. doi: 10.1253/circj.CJ-15-0618. Epub 2015 Oct 8.

10.

Clinical characteristics of responders to treatment with tolvaptan in patients with acute decompensated heart failure: Importance of preserved kidney size.

Toda H, Nakamura K, Nakahama M, Wada T, Watanabe A, Hashimoto K, Terasaka R, Tokioka K, Nishii N, Miyoshi T, Kohno K, Kawai Y, Miyaji K, Koide Y, Tachibana M, Yoshioka R, Ito H; Tolvaptan Registry Investigators.

J Cardiol. 2016 Feb;67(2):177-83. doi: 10.1016/j.jjcc.2015.04.017. Epub 2015 Jun 10.

11.

Association between coronary artery calcification and left ventricular diastolic dysfunction in elderly people.

Osawa K, Miyoshi T, Oe H, Sato S, Nakamura K, Kohno K, Morita H, Kanazawa S, Ito H.

Heart Vessels. 2016 Apr;31(4):499-507. doi: 10.1007/s00380-015-0645-5. Epub 2015 Feb 12.

PMID:
25673497
12.

Omega-3 fatty acids improve postprandial lipemia and associated endothelial dysfunction in healthy individuals - a randomized cross-over trial.

Miyoshi T, Noda Y, Ohno Y, Sugiyama H, Oe H, Nakamura K, Kohno K, Ito H.

Biomed Pharmacother. 2014 Oct;68(8):1071-7. doi: 10.1016/j.biopha.2014.10.008. Epub 2014 Oct 28.

PMID:
25458786
13.

Add-on ezetimibe reduces small dense low-density lipoprotein cholesterol levels without affecting absorption of eicosapentaenoic acid in patients with coronary artery disease: a pilot study.

Kubo M, Miyoshi T, Kimura T, Noda Y, Kohno K, Nakamura K, Morita H, Ito H.

Am J Cardiovasc Drugs. 2014 Oct;14(5):387-92. doi: 10.1007/s40256-014-0082-3.

PMID:
24915983
14.

Pioglitazone prevents the endothelial dysfunction induced by ischemia and reperfusion in healthy subjects.

Sakatani Y, Miyoshi T, Oe H, Noda Y, Ohno Y, Nakamura K, Saito Y, Osawa K, Morita H, Kohno K, Ito H.

J Cardiovasc Pharmacol. 2014 Oct;64(4):326-31. doi: 10.1097/FJC.0000000000000124.

PMID:
24887686
15.

Additional diagnostic value of first-pass myocardial perfusion imaging without stress when combined with 64-row detector coronary CT angiography in patients with coronary artery disease.

Osawa K, Miyoshi T, Koyama Y, Hashimoto K, Sato S, Nakamura K, Nishii N, Kohno K, Morita H, Kanazawa S, Ito H.

Heart. 2014 Jul;100(13):1008-15. doi: 10.1136/heartjnl-2013-305468. Epub 2014 Apr 24.

PMID:
24763490
16.

Bezafibrate improves postprandial hypertriglyceridemia and associated endothelial dysfunction in patients with metabolic syndrome: a randomized crossover study.

Ohno Y, Miyoshi T, Noda Y, Oe H, Toh N, Nakamura K, Kohno K, Morita H, Ito H.

Cardiovasc Diabetol. 2014 Apr 5;13:71. doi: 10.1186/1475-2840-13-71.

17.

Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities.

Tokioka K, Kusano KF, Morita H, Miura D, Nishii N, Nagase S, Nakamura K, Kohno K, Ito H, Ohe T.

J Am Coll Cardiol. 2014 May 27;63(20):2131-2138. doi: 10.1016/j.jacc.2014.01.072. Epub 2014 Apr 2.

18.

Serum cystatin C as a biomarker of cardiac diastolic dysfunction in patients with cardiac disease and preserved ejection fraction.

Nosaka K, Nakamura K, Kusano K, Toh N, Tada T, Miyoshi T, Doi M, Kohno K, Morita H, Ito H.

Congest Heart Fail. 2013 Jul-Aug;19(4):E35-9. doi: 10.1111/chf.12039.

19.

Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis.

Miura A, Akagi S, Nakamura K, Ohta-Ogo K, Hashimoto K, Nagase S, Kohno K, Kusano K, Ogawa A, Matsubara H, Toyooka S, Oto T, Ohtsuka A, Ohe T, Ito H.

Cardiovasc Pathol. 2013 Jul-Aug;22(4):287-93. doi: 10.1016/j.carpath.2012.12.002. Epub 2013 Jan 10.

PMID:
23312620
20.

Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report.

Noda Y, Miyoshi T, Oe H, Ohno Y, Nakamura K, Toh N, Kohno K, Morita H, Kusano K, Ito H.

Cardiovasc Diabetol. 2013 Jan 9;12:8. doi: 10.1186/1475-2840-12-8.

Supplemental Content

Loading ...
Support Center